Wide Preclinical Expertise Porsolt offers comprehensive preclinical CRO services with recognized expertise in in vitro, ex vivo, and in vivo models, making them a valuable partner for drug development projects across diverse therapeutic areas.

Safety Evaluation Solutions With a focus on safety evaluation from drug screening to regulatory studies, Porsolt provides full GLP-compliant services including arrhythmogenic risk assessment and abuse/dependence liability evaluation, addressing critical needs in drug development.

International Reputation Benefit from Porsolt’s international reputation in providing tailored scientific advice and solutions for treatment discovery, positioning your projects for success with the backing of a reputed partner in the research services industry.

Tech-Forward Approach Powered by a tech stack including Google Font API, Swiper, and Adobe Creative Suite, Porsolt integrates technology to enhance service delivery, offering a modern and efficient approach that aligns with contemporary research needs.

Financial Stability With an established revenue in the range of $10M - 50M, Porsolt demonstrates financial stability, assuring clients of a reliable partner for long-term collaboration and providing a strong foundation for potential sales engagements.